Dividend
Dividend
Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 2.5 per equity share.
Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 2.5 per equity share.
Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 2.5 per equity share.